Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-74.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-74.5%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 8.91% |
| 2023 | 23.76% |
| 2022 | 71.01% |
| 2021 | 540.14% |
| 2020 | 434.84% |
| 2019 | -99.45% |
| 2018 | 40.10% |
| 2017 | -28.62% |
| 2016 | 444.39% |
| 2015 | 0.00% |